These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 35861924)

  • 1. Antiseizure Drugs and Movement Disorders.
    Sáenz-Farret M; Tijssen MAJ; Eliashiv D; Fisher RS; Sethi K; Fasano A
    CNS Drugs; 2022 Aug; 36(8):859-876. PubMed ID: 35861924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force.
    Tomson T; Battino D; Bromley R; Kochen S; Meador KJ; Pennell PB; Thomas SV
    Epileptic Disord; 2022 Dec; 24(6):1020-1032. PubMed ID: 36193017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiseizure Medication-Induced Alopecia: A Literature Review.
    Pitton Rissardo J; Fornari Caprara AL; Casares M; Skinner HJ; Hamid U
    Medicines (Basel); 2023 Jun; 10(6):. PubMed ID: 37367730
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
    Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
    Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy.
    Besag FMC; Vasey MJ
    Paediatr Drugs; 2021 May; 23(3):253-286. PubMed ID: 33956338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database.
    Porwal MH; Razzak AN; Kumar V; Obeidat AZ; Sharma U
    Epilepsy Res; 2024 Jul; 203():107382. PubMed ID: 38761467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.
    Knight R; Wittkowski A; Bromley RL
    Epilepsia; 2021 Aug; 62(8):1765-1779. PubMed ID: 34128227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions involving the new second- and third-generation antiepileptic drugs.
    Johannessen Landmark C; Patsalos PN
    Expert Rev Neurother; 2010 Jan; 10(1):119-40. PubMed ID: 20021326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2022 Oct; 36(10):1079-1111. PubMed ID: 36194365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiepileptic drugs in North America].
    Akiyama T; Otsubo H
    Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of cenobamate for focal seizures in people with drug-resistant epilepsy.
    Laskier V; Agyei-Kyeremateng KK; Eddy AE; Patel D; Mulheron S; James S; Thomas RH; Sander JW
    Epilepsia; 2023 Apr; 64(4):843-856. PubMed ID: 36625423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in anti-epileptic drug testing.
    Krasowski MD; McMillin GA
    Clin Chim Acta; 2014 Sep; 436():224-36. PubMed ID: 24925169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.
    Patsalos PN
    Clin Pharmacokinet; 2013 Nov; 52(11):927-66. PubMed ID: 23784470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.
    Patsalos PN
    Clin Pharmacokinet; 2013 Dec; 52(12):1045-61. PubMed ID: 23794036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Antiseizure Medications on Appetite and Weight in Children.
    Buraniqi E; Dabaja H; Wirrell EC
    Paediatr Drugs; 2022 Jul; 24(4):335-363. PubMed ID: 35596110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications.
    Krasowski MD
    Pharmaceuticals (Basel); 2010 Jun; 3(6):1909-1935. PubMed ID: 20640233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antiepileptic drugs in hepatic and renal disease.
    Asconapé JJ
    Handb Clin Neurol; 2014; 119():417-32. PubMed ID: 24365310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of new antiepileptic drugs: a network meta-analysis.
    Zaccara G; Giovannelli F; Giorgi FS; Franco V; Gasparini S; Benedetto U
    Eur J Clin Pharmacol; 2017 Jul; 73(7):811-817. PubMed ID: 28378057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN; Sander JW
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement Disorders Secondary to Novel Antiseizure Medications in Pediatric Populations: A Systematic Review and Meta-analysis of Risk.
    Peacock DJSJ; Yoneda JRK; Siever JE; Vis-Dunbar M; Boelman C
    J Child Neurol; 2022 May; 37(6):524-533. PubMed ID: 35392704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.